Please assess the completion status of the following clinical trial:

Trial Title: Ropivacaine Though Laterosternal Catheters After Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Scheduled cardiac surgery.~Exclusion Criteria:~* - surgery in emergency~* thoracotomy~* cardiac graft~* redo~* pregnancy~* patient's refusal~* minor or adult under legal protection~* psychiatric ongoing disease~* addiction to opiates~* ongoing opiate treatment~* inability to use a PCA device~* respiratory insuffiency (Vital capacity or maximal expired volume per sec. \< 50% of the expected value, or mean PAP \> 50 mmHg)~* intra-aortic balloon~* severe renal insuffiency~* history of allergy or intolerance to: morphine, acetaminophen, bupivacaine.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- ropivacaine (Type: EXPERIMENTAL): None
- normal saline (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).